SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-007783
Filing Date
2012-02-06
Accepted
2012-02-06 16:15:24
Documents
2
Period of Report
2012-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6802
2 POA DOCUMENT poa.txt EX-24.4_407875 3573
  Complete submission text file 0001209191-12-007783.txt   11642
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139
Business Address
Stamoulis Christiana (Reporting) CIK: 0001502917 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 12573793